ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.145
+0.005 (0.44%)
Apr 17, 2025, 4:00 PM EDT - Market closed
ProQR Therapeutics Employees
ProQR Therapeutics had 166 employees as of December 31, 2024. The number of employees increased by 10 or 6.07% compared to the previous year.
Employees
166
Change (1Y)
10
Growth (1Y)
6.07%
Revenue / Employee
$121,824
Profits / Employee
-$173,047
Market Cap
119.94M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
PRQR News
- 4 days ago - ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth - GlobeNewsWire
- 5 weeks ago - ProQR Announces Year End 2024 Operating and Financial Results - GlobeNewsWire
- 4 months ago - ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist - GlobeNewsWire
- 6 months ago - ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement - GlobeNewsWire
- 6 months ago - ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement - GlobeNewsWire
- 6 months ago - ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares - GlobeNewsWire
- 6 months ago - ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society - GlobeNewsWire
- 7 months ago - ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire